Characterization of a human myxoid malignant fibrous histiocytoma cell line, OH931

Cancer Genetics and Cytogenetics

Volumn 94, Issue 2, 1997, Pages 138-143

  Krause, Amber K ^a,b   Hinrichs, Steven H ^a,b   Orndal, Charlotte ^a,b   DeBoer, Joanne ^a   Neff, James R ^a,b   Bridge, Julia A ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; DERMATOFIBROMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MORPHOLOGY; MYXOMA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS;

AGED; ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; GLYCOSAMINOGLYCANS; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; KARYOTYPING; MICE; MICE, NUDE; MICROSCOPY, ELECTRON; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030890722     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00223-3     Document Type: Article

References (19)

1. Enzinger FM, Weiss SW (1988): Soft Tissue Tumors, ed. 2, CV Mosby, St. Louis, pp. 269-300.
2. Weiss SW, Enzinger FM (1977): Myxoid variant of malignant fibrous histiocytoma. Cancer 39:1672-1685.
3. Mandahl N, Heim S, Willen H, Rydholm A, Eneroth M, Nilbert M, Kreicbergs A, Mitelman F (1989): Characteristic karyotypic anomalies identify subtypes of malignant fibrous histiocytoma. Genes Chromosom Cancer 1:9-14.
4. Sandberg AA, Bridge JA (1994): The Cytogenetics of Bone and Soft Tissue Tumors. RG Landes, Austin, pp. 61-73.
5. Orndal C, Mandahl N, Rydholm A, Willen A, Brosjo O, Heim S, Mitelman F (1992): Supernumerary ring chromosomes in five bone and soft tissue tumors of low or borderline malignancy. Cancer Genet Cytogenet 60:170-175.
6. Mandahl N, Heim S, Kristofferson U, Mitelman F, Rooser B, Rydholm A, Willen H (1985): Telomeric association in a MFH. Hum Genet 71:321-324.
7. Iwasaki H, Isayama T, Ohjimi Y, Kikuchi M, Yoh S, Shinohara N, Yoshitake K, Ishiguro M, Kamada N, Enjoji M (1992): Malignant fibrous histiocytoma: A tumor of facultative histiocytes showing mesenchymal differentiation in cultured cell lines. Cancer 69:437-447.
8. Roholl PJM, Prinsen LP, Rademakers LPHM, Hsu S-M, Van Unnik JAM (1991): Two cell lines with epithelial cell-like characteristics established from malignant fibrous histiocytomas. Cancer 68:1963-1972.
9. Kanzaki T, Kitajima S, Suzumori K (1991): Biological behavior of cloned cells of human malignant fibrous histiocytoma in Vivo and in Vitro. Cancer Res 51:2133-2137.
10. Yamate J, Masanori T, Togo M, Shibuya K, Ihara M, Kudow S (1991): Heterogeneity of cloned cells established from a transplantable rat malignant fibrous histiocytoma. Jap J Cancer Res 82:298-307.
11. Genberg M, Mark J, Hakelius L, Ericsson J, Nister M (1989): Origin and relationship between different cell types in MFH, Ame J Pathol 135:1185-1196.
12. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
13. Hinrichs SH, Jaramillo MA, Gumerlock PH, Gardner MB, Lewis JP, Freeman AE (1985): Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22. Cancer Genet Cytogenet 14:219-226.
14. Sheenan D (1974): Theory and Practise of Histotechnology, CV Moshy, St. Louis, p. 97.
15. Heim S, Mitelman F (1995): Cancer Cytogenetics, ed 2, Alan R. Liss, Inc., New York, pp. 477-513.
16. Cockerill GW, Gamble JR, Vadas MA (1995): Angiogenesis: Models and modulators. Int Rev Cytol 159:113-160.
17. Feinberg RN, Beebe DC (1983): Hyaluronate in vasculogenesis. Science 220:1177-1179.
18. West DC, Hampson IN, Arnold F, Kumar S (1985): Angiogenesis induced by degradation products of hyaluronic acid. Science 228:1324-1326.
19. Jones LM, Gardner MJ, Catterall JB, Turner GA (1995): Hyaluronic acid secreted by mesothelial cells: A natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis 13:373-380.